Tirzepatide use linked to GI adverse events in dose dependant manner Written By Medha Baranwal26 April 2023 11:00 AM ISTUSA: A systematic review published in the Journal of the Endocrine Society details the incidence rate of each adverse event at three tirzepatide doses...
Azithromycin no better than placebo among patients of LRTI with low procalcitonin levels: Lancet Written By Dr.Niharika Harsha B19 Dec 2022 8:00 PM ISTA recent trial found that in adults with lower respiratory tract infections and lower procalcitonin concentration, the placebo was not non-inferior to...
Lebrikizumab as safe as placebo among adults and adolescents with uncontrolled asthma Written By Dr. Kamal Kant Kohli27 Nov 2022 8:00 PM ISTU.S.A: According to research findings presented at the American College of Allergy, Asthma & Immunology (ACAAI) 2022 Annual Scientific Meeting,...
Therapy with high dose of PPIs may benefit children with eosinophilic esophagitis Written By Dr. Kamal Kant Kohli27 Nov 2022 8:00 PM ISTSPAIN: According to a study published in the Journal of Pediatric Gastroenterology and Nutrition, a significant fraction of children with clinical,...
Dose Escalation of Lenvatinib effective for Differentiated Thyroid Carcinoma, study finds Written By Dr.Niharika Harsha B6 July 2022 7:30 PM ISTDose escalation of Lenvatinib has successfully been used to treat Differentiated Thyroid carcinoma (DTC) based on a study that was published in the...
High-dose vitamin D not tied to adverse events in kids upto 6 years of age: JAMA Written By Medical Dialogues Editorial Team19 April 2022 9:15 AM ISTDenmark: In children aged 0 to 6 years, high-dose vitamin D supplementation was not linked with an increased risk of severe adverse events (SAEs), and...
House dust mite sublingual immunotherapy effective for allergic asthma: Study Written By Dr. Shravani Dali25 Feb 2022 9:00 AM ISTHouse dust mite sublingual immunotherapy may be effective for allergic asthma, according to a recent study published in the Journal of Allergy and...
Limiting alcohol intake may influence likelihood of developing MTX-related adverse events Written By Dr. Shravani Dali17 Nov 2021 9:00 AM ISTMethotrexate (MTX) is known to induce side effects like nausea and alopecia.Limiting alcohol consumption may influence likelihood of developing...
Febuxostat has similar CV safety as Allopurinol when used in Gout: Study Written By Dr. Shravani Dali19 July 2021 9:30 AM ISTFebuxostat used for Gout did not substantially increase the risk of cardiovascular events or death when compared to the usage of Allopurinol,...
Risk: Benefit Profile of Sodium-Glucose Cotransporter 2 Inhibitors: JCEM Written By Dr Kartikeya Kohli17 May 2021 11:30 AM ISTSodium-glucose cotransporter 2 inhibitors (SGLT2i) are first-line antidiabetic agents with demonstrated cardiovascular benefits. In a recent...
Use of corticosteroid Eluting Stents may increase infection risk after sinus surgery Written By MD Bureau19 April 2021 6:15 AM ISTImplantation of sinus stents and spacers can be used as adjuvant management to maintain patency of sinuses after endoscopic sinus surgery for chronic...
No info to CDSCO about specific severe adverse event linked to Covid-19 vaccines: MoS Health Medical Dialogues Bureau6 Feb 2021 5:31 PM IST"If any vaccine recipient develops symptoms of COVID19, vaccine recipient will be provided a medically recognized standard of care in the government...
